VLP Therapeutics announced the U.S. Food and Drug Administration (FDA) has cleared an investigational new drug (IND) application for a clinical trial of the Company's VLPM01 malaria vaccine....
The new grant from the GHIT Fund will further development of processes to move the vaccine from the experimental stage to human trials and, ultimately, a clinical treatment.